MétaCan
Menu
Back to cohort

1161 Novel cyclophilin inhibitors could serve as an NK cell-stimulating immunotherapy for triple negative breast cancer

2025· article· W4416076177 on OpenAlexfundno aff
Dahlia Doughty Shenton

Bibliographic record

VenueRegular and Young Investigator Award Abstracts · 2025
Typearticle
Language
FieldBiochemistry, Genetics and Molecular Biology
TopicSignaling Pathways in Disease
Canadian institutionsnot available
FundersInstitute of GeneticsInternational Seafood Sustainability Foundation
KeywordsImmunotherapyTriple-negative breast cancerCyclophilin ACancer immunotherapyBreast cancer

Abstract

fetched live from OpenAlex

Background Breast cancer is the most common cancer worldwide and triple negative breast cancer accounts for 15-20% of cases.Triple negative breast cancer has a high recurrence rate and high mortality.Significant levels of tumour-infiltrating lymphocytes within solid tumours make triple negative breast cancer a good candidate for immunotherapy.We have developed small molecule cyclophilin inhibitors, which by binding the natural killer triggering receptor, boost the ability of natural killer cells to kill triple negative breast cancer cells.Methods The NK92 natural killer cell line was co-cultured with the MDA-MB-231 triple negative breast cancer cell line in the presence of 10 mM cyclophilin inhibitor and cultures were imaged over 72 hours.The apoptotic fraction of the target cancer cell population in the presence and absence of cyclophilin inhibitor was then quantified.This cytolysis assay was also carried out with the addition of induced pluripotent stem cell-derived macrophages programmed in vitro to an immune suppressive phenotype.Results Live cell imaging of co-cultures (n=4) demonstrated that the novel cyclophilin inhibitors enhanced NK92-induced apoptosis of MDA-MB-231 cells up to 5-fold (p<0.0001) at 48 hours where peak apoptosis was observed.The inhibitors did not induce significant apoptosis of the cancer cells in the absence of NK92 cells and the efficacy of the inhibitors in enhancing NK92 cytolytic ability reflected the affinity of the inhibitors for the target cyclophilin determined by surface plasmon resonance.Interestingly, one of the inhibitors induced a 3-fold enhancement of NK92-induced killing compared to control while the effect of the S-enantiomer of this inhibitor was insignificant.The inhibitors enhanced NK92-induced apoptosis of target cancer cells even when immune-suppressive macrophages were present.Conclusions Together these data demonstrate that our novel small molecule inhibitors of the natural killer triggering receptor enhance the ability of natural killer cells to kill target triple negative breast cancers cells.This occurs even when immune-suppressive macrophages are present, suggesting these inhibitors could be developed as an immunotherapy and deployed in the neoadjuvant or adjuvant setting.As these molecules act on natural killer cells, they could potentially be combined with other immunotherapies such as checkpoint inhibitors, adoptive immunotherapies and CAR-NK cells for increased efficacy.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.001
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.009
Threshold uncertainty score0.999

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.001
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.000
Science and technology studies0.0010.001
Scholarly communication0.0000.000
Open science0.0010.000
Research integrity0.0010.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.013
GPT teacher head0.281
Teacher spread0.269 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueRegular and Young Investigator Award AbstractsSame topicSignaling Pathways in DiseaseFrench-language works237,207